VOYA Investment Management’s Sutro Biopharma STRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,649
Closed -$23.7K 2742
2025
Q1
$23.7K Buy
3,649
+434
+13% +$6.83K ﹤0.01% 2611
2024
Q4
$59.2K Buy
3,215
+62
+2% +$1.89K ﹤0.01% 2658
2024
Q3
$109K Buy
3,153
+356
+13% +$14K ﹤0.01% 2643
2024
Q2
$81.9K Buy
2,797
+791
+39% +$31.3K ﹤0.01% 2716
2024
Q1
$113K Sell
2,006
-596
-23% -$26.3K ﹤0.01% 2604
2023
Q4
$112K Buy
2,602
+132
+5% +$4.19K ﹤0.01% 2733
2023
Q3
$85.7K Hold
2,470
﹤0.01% 2768
2023
Q2
$115K Buy
2,470
+474
+24% +$23.6K ﹤0.01% 2752
2023
Q1
$92.2K Hold
1,996
﹤0.01% 2712
2022
Q4
$161K Hold
1,996
﹤0.01% 2636
2022
Q3
$111K Buy
1,996
+285
+17% +$16.9K ﹤0.01% 2753
2022
Q2
$89K Hold
1,711
﹤0.01% 2643
2022
Q1
$141K Hold
1,711
﹤0.01% 2449
2021
Q4
$255K Buy
1,711
+13
+0.8% +$2.33K ﹤0.01% 2383
2021
Q3
$321K Hold
1,698
﹤0.01% 2302
2021
Q2
$316K Buy
1,698
+336
+25% +$65.8K ﹤0.01% 2350
2021
Q1
$310K Buy
1,362
+186
+16% +$44.1K ﹤0.01% 2301
2020
Q4
$255K Buy
+1,176
New +$195K ﹤0.01% 2286

Other funds holding STRO

VOYA Investment Management's STRO Position: Q2 2025 in Review

VOYA Investment Management sold out of Sutro Biopharma (STRO) in Q2 2025, closing a stake of 3,649 shares — an estimated $23.7K sold.

VOYA Investment Management first reported a position in STRO in Q4 2020 and held it in 18 quarters. The position peaked at $321K in Q3 2021. 99 funds tracked by Wall St. Rank hold STRO as of Q2 2025.

  • VOYA Investment Management reported no remaining Sutro Biopharma position as of Q2 2025 after selling out during the quarter.
  • VOYA Investment Management sold 3,649 Sutro Biopharma shares in Q2 2025, an estimated $23.7K.
  • VOYA Investment Management first reported a position in Sutro Biopharma in Q4 2020 and held it in 18 quarters.
  • VOYA Investment Management's Sutro Biopharma position peaked at $321K in Q3 2021.
  • 99 funds tracked by Wall St. Rank held Sutro Biopharma as of Q2 2025.

Based on VOYA Investment Management's 13F filing for Q2 2025, filed 14 Aug 2025.